Facebook
Twitter
LinkedIn
ForwardAppropriate Utilization of Troponin, Pro-BNP and D-dimer in the Clinical Setting: State of the Art
This course provides practitioners with latest evidence-based guidelines for the appropriate use of troponin, D-dimer and Pro-BNP.
NOTE: Physicians should bookmark this course to access all protocols, policies and procedures at your convenience via your CME Portal account. All algorithms will be available on CERNER.
Target Audience
Miami Cardiac & Vascular Institute affiliated physicians as well as other interested cardiologists, interventional cardiologists, hospitalists and physician assistants.
Learning Objectives
- Utilize troponin appropriately in the assessment of patients with chest pain.
- Determine when it is and is not appropriate to order Pro-BNP and D-dimer in the assessment of patients with congestive heart failure.
- Recognize the clinical and economic consequences of inappropriate use of these signature tests.
Theodore Feldman, M.D., FACC, FACP
Medical Director, Wellness and Prevention, Baptist Health South Florida
Medical Director, Prevention and Community Health, Miami Cardiac & Vascular Institute
Chief of Cardiology, Clinical Associate Professor of Medicine, Herbert Wertheim College of Medicine at Florida International University
Javier Jimenez-Carcamo, M.D.
Director, Advanced Heart Failure and Pulmonary Hypertension, Baptist Health South Florida
Voluntary Associate Professor of Medicine, University of Miami Miller School of Medicine
Clinical Associate Professor of Medicine, Herbert Wertheim College of Medicine at Florida International University
Sebastian A. Abdelnur, M.D.
Emergency Medicine Physician
Associate Director, Adult Emergency Department, West Kendall Baptist Hospital
Baptist Health Quality Network
Baptist Health South Florida
Sebastian A. Abdelnur, M.D., Javier Jimenez-Carcamo, M.D., and Theodore Feldman, M.D., have indicated that neither they nor their spouses/partners have relevant financial relationships with commercial interest companies, and they will not include off-label product usage in their presentations or discussions.
Ricardo Cury, M.D., receives grant/research support from GE Healthcare.
Ramon Lloret, M.D., is a member of the speakers bureau for Aralez Pharmaceuticals, Astra Zeneca and Novartis.
All other Troponin, Pro-BNP and D-dimer utilization committee members as well as non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 0.75 AMA PRA Category 1 Credit™
- 0.75 General certificate of attendance
Required Hardware/Software
 | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
 | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
 | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |
